Wells Fargo & Company AMPHASTAR PHARMACEUTICALS IN Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
Number of Shares
7,550,000
Previous 7,042,000
7.21%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%